Skip to content

AMN Healthcare AMN Company-owned life insurance policies

Company-owned life insurance policies at other companies

EVR
EvergyEVRG
-$2.73M+8.4%
Capital City Bank Group logo
Capital City Bank GroupCCBG
$52.75K+5.0%
Western Alliance Bancorporation logo
Western Alliance BancorporationWAL
$6.3M-19.0%
Brighthouse Financial logo
Brighthouse FinancialBHF
$3M0.0%
SS&C Technologies logo
SS&C TechnologiesSSNC
$4.43M
RBC Bearings logo
RBC BearingsRBC
-$50K+75.0%

Other financials

Income statement

See full
Revenue$1.4B+99.9%
Gross profit$368.8M+86.2%
Operating income$117.2M+837%
Net income$62.2M+5,793%
EPS (diluted)$1.59+5,400%

Balance sheet

See full
Cash & equivalents$595.0M+528%
Total debt$776.9M-12.4%
Total equity$712.8M-0.3%
Total assets$2.6B+8.7%

Cash flow

See full
Operating cash flow$562.5M+507%
CapEx$7.2M-27.4%
Free cash flow$555.2M+571%

Valuation

See full
Market cap$1.23B+49.8%
Enterprise value$1.41B-11.9%
P/S0.4×+0.1×

Profitability

See full
Gross margin27.6%-2.5pp
Operating margin-9.8%-14.2pp
Net margin-0.9%-0.4pp
FCF margin20.7%+11.6pp

Returns & leverage

See full
Return on equity-4.5%-2.0pp
Debt / equity1.1×-0.2×
Current ratio1.1×0.0×

Where this comes from

Reported directly by AMN Healthcare in its filing.

Tagged under the XBRL concept amn:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseCompanyOwnedLifeInsurancePercent.

The official record: AMN Healthcare’s 10-K, filed February 20, 2026, on SEC EDGAR. View the filing →

Ask your AI about AMN Healthcare's company-owned life insurance policies.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is AMN Healthcare's company-owned life insurance policies?
AMN Healthcare (AMN) reported company-owned life insurance policies of 6.2% in Q4 2025.
What does company-owned life insurance policies mean?
Reflects the reconciliation adjustment for company-owned life insurance policies within the effective tax rate calculation. It isolates the tax effect of policy-related gains or expenses that do not align with standard statutory tax treatment.